Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Type 1 diabetes
Pharma
Sanofi asks out of FDA's CNPV program for Tzield expansion: Stat
Sanofi has asked that its label expansion application for Tzield be taken out of the controversial priority review program.
Kevin Dunleavy
May 6, 2026 4:00pm
GenEdit rebrands as BreezeBio, raises $60M for genetic drug R&D
Feb 25, 2026 7:00am
Medtronic MiniMed campaign pushes people with T1D to 'Own It'
Dec 18, 2025 12:05pm
Sanofi expands price cut to $35 monthly for all insulin products
Sep 26, 2025 1:00pm
Europe's CHMP gives nods to Novo's Kyinsu, Bayer's Lynkuet
Sep 19, 2025 10:45am
Insulet, Medtronic laud debut of Barbie with Type 1 diabetes
Jul 10, 2025 12:26pm
